𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cost-effectiveness analysis: What is it and how it influence neurology

✍ Scribed by Dr Robert G. Holloway

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
650 KB
Volume
39
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

✦ Synopsis

Cost-effectiveness analysis (CEX) refers to a set of research methods that consider the resources consumed by a medical technology in decisions about how best to use the technology. This analytic method is an evolving, controversial, and often misunderstood field in health services research. The basic set of principles underlying CEA is deceptively simple, but sufficient methodological challenges and controversies exist that have, thus far, limited its use in the development of health policy and in bedside decision making. Nonetheless, neurologists like other specialty groups may feel concerned that the results from such analyses may prove unfavorable to their specialty and the patients they serve. This article reviews the fundamental notions surrounding CEA, provides examples from the literature with particular relevance to the neurological community, and highlights critical issues for neurologists regarding the future of CEA.

πŸ“œ SIMILAR VOLUMES

Multiple imputation by chained equations
Multiple imputation by chained equations: what is it and how does it work?
✍ Melissa J. Azur; Elizabeth A. Stuart; Constantine Frangakis; Philip J. Leaf πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 121 KB πŸ‘ 1 views

## Abstract Multivariate imputation by chained equations (MICE) has emerged as a principled method of dealing with missing data. Despite properties that make MICE particularly useful for large imputation procedures and advances in software development that now make it accessible to many researchers

Does NICE have a cost-effectiveness thre
Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis
✍ Nancy Devlin; David Parkin πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 217 KB

## Abstract The decisions made by the National Institute for Clinical Excellence (NICE) give rise to two questions: how is cost‐effectiveness evidence used to make judgements about the β€˜value for money’ of health technologies? And how are factors other than cost‐effectiveness taken into account? Th

Capacity development for agricultural bi
Capacity development for agricultural biotechnology in developing countries: an innovation systems view of what it is and how to develop it
✍ Andy Hall πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 145 KB

## Abstract There are divergent views on what capacity development might mean in relation to agricultural biotechnology. The core of this debate is whether this should involve the development of human capital and research infrastructure, or whether it should encompass a wider range of activities wh

Genetic counseling program in familial b
Genetic counseling program in familial breast cancer: Analysis of its effectiveness, cost and cost-effectiveness ratio
✍ Judith BalmaΓ±a; Judit Sanz; Xavier Bonfill; Alfonso Casado; Montse RuΓ©; Ignasi G πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 95 KB πŸ‘ 1 views

## Abstract Women with a family history of breast cancer are at increased risk for developing this neoplasm. Starting surveillance more frequently at a younger age than the general population and the possibility of undergoing genetic testing are options for their medical management. We analyzed the